Los Angeles,
07:18 AM

Cedars-Sinai Cancer Welcomes New Specialists to Breast Cancer Team

Kjirsten Carlson Betz, MD, and Marissa Boyle, MD, Join Division of Surgical Oncology

Breast surgical oncologists Kjirsten Carlson Betz, MD, and Marissa Boyle, MD, have joined the Cedars-Sinai Cancer Division of Surgical Oncology.

“We’re pleased to welcome Drs. Carlson Betz and Boyle to Cedars-Sinai Cancer,” said Armando E. Giuliano, MD, regional medical director of the Cedars-Sinai Breast Oncology Program. “Both are highly skilled, outstanding additions to our team, bringing additional expertise, compassion and commitment to patients who rely on Cedars-Sinai for leading-edge breast cancer treatment and care.”

Kjirsten Carlson BetzCarlson Betz earned her medical degree from Rush Medical College of Rush University in Chicago and completed her general surgery residency at Cedars-Sinai, where she received the Leo Rigler, MD,  Award for Clinical Excellence. She also completed a breast surgery research fellowship at Cedars-Sinai and a breast surgical oncology fellowship at MD Anderson Cancer Center, where she received The Corynne S. Uhl Award for Compassion and Excellence in Patient Care. Carlson Betz will treat patients at Cedars-Sinai Marina del Rey Hospital as well as at Cedars-Sinai Medical Center.

Boyle earned a medical degree from Keck School of Medicine of the University of Southern California and completed her surgery residency at Cedars-Sinai, where she received an American Society of Clinical Oncology Merit Award and Rubenstein Award for Excellence in Resident Research. She completed her fellowship in breast surgical oncology at Memorial Sloan Kettering Cancer Center. She will treat patients at the Cedars-Sinai main campus.

Cedars-Sinai Cancer, ranked #11 in the nation in U.S. News & World Report’s “Best Hospitals 2022-23,” is renowned for its groundbreaking strides in cancer prevention, treatments andMarissa Boyle, MD precision medicine. The hospital is proud to serve the most diverse population in the country and is working to expand access for those who often lack quality care.

Cedars-Sinai Cancer has developed an evidence-based, community-focused approach to breast cancer care. In addressing declining minority participation in cancer clinical trials, Cedars-Sinai Cancer has established the Equitable Pathways to Cures for Breast Cancer effort, which calls upon multicultural and multilingual enrollment navigators to help improve clinical trial awareness and enrollment.

Additionally, its Cancer Research Center for Health Equity is addressing the increase of breast cancer in the Korean community by raising awareness about the disease and screening guidelines among Korean American women. Research is also underway to better understand the causes of breast cancer in Koreans.

“We always aim to recruit talented physicians, researchers and fellows as part of our commitment to bringing exceptional research and care to patients,” said Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer and the PHASE ONE Foundation Distinguished Chair. “Our Breast Oncology Program is renowned for its superb expertise and highest quality of care. I’m grateful that Dr. Carlson Betz and Dr. Boyle have joined us in this effort and welcome them aboard.”

Read more on the Cedars-Sinai Blog: Standing Up to Stage 4 Breast Cancer